Effect of sea buckthorn (Hippophae rhamnoides L.) on blood lipid profiles: A systematic review and meta-analysis from 11 independent randomized controlled trials

Trends in Food Science and Technology

Volumn 61, Issue , 2017, Pages 1-10

  Guo, Xiao fei ^a   Yang, Bo ^a   Cai, Wenwen ^a   Li, Duo ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Blood lipid profiles; Meta analysis; Randomized controlled trial; Sea buckthorn

Indexed keywords

BLOOD; LIPIDS;

CARDIOVASCULAR RISK; HIPPOPHAE RHAMNOIDES; LIPID PROFILE; META ANALYSIS; PROTECTIVE EFFECTS; RANDOMIZED CONTROLLED TRIAL; SEA BUCKTHORN; TOTAL CHOLESTEROLS;

CHOLESTEROL;

EID: 85009451897     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tifs.2016.11.007     Document Type: Review

References (70)

1. Aimulaguli, A., Zhang, Y., Effect on mice blood sugar and blood grease with hippophae. Journal of Xinjiang Normal University 27 (2008), 39–41 Natural Sciences Edition.
2. Arai, Y., Watanabe, S., Kimira, M., Shimoi, K., Mochizuki, R., Kinae, N., Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. The Journal of Nutrition 130 (2000), 2243–2250.
3. Arts, I.C., Hollman, P.C., Polyphenols and disease risk in epidemiologic studies. The American Journal of Clinical Nutrition 81 (2005), 317S–325S.
4. Bal, L.M., Meda, V., Naik, S., Satya, S., Sea buckthorn berries: A potential source of valuable nutrients for nutraceuticals and cosmoceuticals. Food Research International 44 (2011), 1718–1727.
5. Bao, M., Lou, Y., Flavonoids from seabuckthorn protect endothelial cells (EA. hy926) from oxidized low-density lipoprotein induced injuries via regulation of LOX-1 and eNOS expression. Journal of Cardiovascular Pharmacology 48 (2006), 834–841.
6. Brown, B.G., Stukovsky, K.H., Zhao, X.-Q., Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: A meta-analysis of 23 randomized lipid trials. Current Opinion in Lipidology 17 (2006), 631–636.
7. Calder, P.C., Mechanisms of action of (n-3) fatty acids. The Journal of Nutrition 142 (2012), 592S–599S.
8. Cao, Q., Qu, W., Deng, Y., Zhang, Z., Niu, W., Pan, Y., Effect of flavonoids from the seed and fruit residue of hippophae rhamnoides L.on glycometabolism inMice. Journal of Chinese Medicinal Materials 26 (2003), 735–737 (Chinese).
9. Chapman, M.J., The potential role of HDL-and LDL-cholesterol modulation in atheromatous plaque development. Current Medical Research and Opinion 21 (2005), S17–S22.
10. DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Controlled Clinical Trials 7 (1986), 177–188.
11. Durrington, P., Soran, H., Hyperlipidemia. Metabolism of human diseases. 2014, Springer.
12. Eccleston, C., Baoru, Y., Tahvonen, R., Kallio, H., Rimbach, G.H., Minihane, A.M., Effects of an antioxidant-rich juice (sea buckthorn) on risk factors for coronary heart disease in humans. Journal of Nutritional Biochemistry 13 (2002), 346–354.
13. Egger, M., Smith, G.D., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315 (1997), 629–634.
14. Forman, H.J., Davies, K.J., Ursini, F., How do nutritional antioxidants really work: Nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radical Biology and Medicine 66 (2014), 24–35.
15. Fukumitsu, S., Villareal, M.O., Onaga, S., Aida, K., Han, J., Isoda, H., α-Linolenic acid suppresses cholesterol and triacylglycerol biosynthesis pathway by suppressing SREBP-2, SREBP-1a and-1c expression. Cytotechnology 65 (2013), 899–907.
16. Gao, Z., Zhang, C., Jin, L., Yao, W., Efficacy of aea buckthorn therapy in patients with nonalcoholic fatty liver disease. Chinese Medicine 5 (2014), 223–230 (Chinese).
17. Gnoni, G., Paglialonga, G., Siculella, L., Quercetin inhibits fatty acid and triacylglycerol synthesis in rat-liver cells. European Journal of Clinical Investigation 39 (2009), 761–768.
18. Grad, S.C., Muresan, I., Dumitrascu, D.L., Generalized yellow skin caused by high intake of sea buckthorn. Forschende Komplementärmedizin/Research in Complementary Medicine 19 (2012), 153–156.
19. Gregor, M.F., Hotamisligil, G.S., Inflammatory mechanisms in obesity. Annual Review of Immunology 29 (2011), 415–445.
20. Higgins, J., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. British Medical Journal, 343, 2011, d5928.
21. Hokanson, J.E., Austin, M.A., Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A metaanalysis of population-based prospective studies. Journal of Cardiovascular Risk 3 (1996), 213–219.
22. Huang, M., Zhang, Y., Han, P., Tang, M., Effect of Fufangshaji capsule in treatment of non-alcohic fatty liver disease. Medical Journal of West China 24 (2012), 359–361 (Chinese).
23. Johansson, A.K., Korte, H., Yang, B., Stanley, J.C., Kallio, H.P., Sea buckthorn berry oil inhibits platelet aggregation. Journal of Nutritional Biochemistry 11 (2000), 491–495.
24. JuŸwiak, S., Wójcicki, J., Mokrzycki, K., Marchlewicz, M., Białecka, M., Wenda-Różewicka, L., et al. Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits. Pharmacological Reports 57 (2005), 604–609.
25. Kaminski, B.M., Steinhilber, D.M., Stein, J., Ulrich, S., Phytochemicals resveratrol and sulforaphane as potential agents for enhancing the anti-tumor activities of conventional cancer therapies. Current Pharmaceutical Biotechnology 13 (2012), 137–146.
26. Koo, S.I., Noh, S.K., Green tea as inhibitor of the intestinal absorption of lipids: Potential mechanism for its lipid-lowering effect. The Journal of Nutritional Biochemistry 18 (2007), 179–183.
27. Larmo, P., Alin, J., Salminen, E., Kallio, H., Tahvonen, R., Effects of sea buckthorn berries on infections and inflammation: A double-blind, randomized, placebo-controlled trial. European Journal of Clinical Nutrition 62 (2008), 1123–1130.
28. Larmo, P.S., Jarvinen, R.L., Setala, N.L., Yang, B., Viitanen, M.H., Engblom, J.R., et al. Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye. The Journal of Nutrition 140 (2010), 1462–1468.
29. Larmo, P.S., Kangas, A.J., Soininen, P., Lehtonen, H.M., Suomela, J.P., Yang, B., et al. Effects of sea buckthorn and bilberry on serum metabolites differ according to baseline metabolic profiles in overweight women: A randomized crossover trial. The American Journal Clinical Nutrition 98 (2013), 941–951.
30. Larmo, P.S., Yang, B., Hurme, S.A.M., Alin, J.A., Kallio, H.P., Salminen, E.K., et al. Effect of a low dose of sea buckthorn berries on circulating concentrations of cholesterol, triacylglycerols, and flavonols in healthy adults. European Journal of Nutrition 48 (2009), 277–282.
31. Libby, P., Schoenbeck, U., Mach, F., Selwyn, A.P., Ganz, P., Current concepts in cardiovascular pathology: The role of LDL cholesterol in plaque rupture and stabilization. The American Journal of Medicine 104 (1998), 14S–18S.
32. Li, Y., Gao, Z., Zhang, C., Fang, Q., Yao, W., Jin, L., Clinical study on the treatment with Chinese medicine sea buckthorn on non-alcoholic fatty liver. Mordern Journal of Integrated Traditional Chinese and Western Medicine, 2012, 1485–1486 1494. (Chinese).
33. Liu, Y., Sun, R., Wang, Y., Liu, R., Jin, F., Primary observation of Yinzhian oral liquid from Sea buckthorn in subjects with hyperlipidemia. Hippophae, 2001, 35–37 (Chinese).
34. Liu, K., Zhou, R., Wang, B., Mi, M.-T., Effect of resveratrol on glucose control and insulin sensitivity: A meta-analysis of 11 randomized controlled trials. The American Journal of Clinical Nutrition 99 (2014), 1510–1519.
35. Ma, G., Yang, C., Qu, Y., Wei, H., Zhang, T., Zhang, N., The flavonoid component isorhamnetin in vitro inhibits proliferation and induces apoptosis in Eca-109 cells. Chemico-Biological Interactions 167 (2007), 153–160.
36. Mente, A., de Koning, L., Shannon, H.S., Anand, S.S., A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Archives of Internal Medicine 169 (2009), 659–669.
37. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine 151 (2009), 264–269.
38. Moher, D., Pham, B., Jones, A., Cook, D.J., Jadad, A.R., Moher, M., et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. The Lancet 352 (1998), 609–613.
39. Mozaffarian, D., Cao, H., King, I.B., Lemaitre, R.N., Song, X., Siscovick, D.S., et al. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in US adults: A cohort study. Annals of Internal Medicine 153 (2010), 790–799.
40. Mozaffarian, D., Cao, H., King, I.B., Lemaitre, R.N., Song, X., Siscovick, D.S., et al. Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. The American Journal of Clinical Nutrition 92 (2010), 1350–1358.
41. Niu, T., Preliminary observation of sea buckthorn oral liquid in subjects with hyperlipidemia. Hippophae, 1997, 36–38 (Chinese).
42. Odbayar, T.-O., Badamhand, D., Kimura, T., Takahashi, Y., Tsushida, T., Ide, T., Comparative studies of some phenolic compounds (quercetin, rutin, and ferulic acid) affecting hepatic fatty acid synthesis in mice. Journal of Agricultural and Food Chemistry 54 (2006), 8261–8265.
43. Ridker, P.M., Kastelein, J.J., Genest, J., Koenig, W., C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care. European Heart Journal 34 (2013), 1258–1261.
44. Rösch, D., Bergmann, M., Knorr, D., Kroh, L.W., Structure-antioxidant efficiency relationships of phenolic compounds and their contribution to the antioxidant activity of sea buckthorn juice. Journal of Agricultural and Food Chemistry 51 (2003), 4233–4239.
45. Saggu, S., Divekar, H., Gupta, V., Sawhney, R., Banerjee, P., Kumar, R., Adaptogenic and safety evaluation of seabuckthorn (hippophae rhamnoides) leaf extract: A dose dependent study. Food and Chemical Toxicology 45 (2007), 609–617.
46. Sayegh, M., Miglio, C., Ray, S., Potential cardiovascular implications of Sea Buckthorn berry consumption in humans. International Journal of Food Sciences and Nutrition 65 (2014), 521–528.
47. Schulz, K.F., Altman, D.G., Moher, D., CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMC Medicine 8 (2010), 18–26.
48. Silva, S., Bronze, M.R., Figueira, M.E., Siwy, J., Mischak, H., Combet, E., et al. Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): A randomized, parallel, controlled, double-blind study. The American Journal of Clinical Nutrition 101 (2015), 44–54.
49. Song, C., Du, J., Ge, H., Research of Hippophae rhamnoides fruits on serum lipids and liver protection effects in high-fat-diet rats. Journal of Hygiene Research 4 (2015), 628–631 (Chinese).
50. Sugano, M., Morioka, H., Ikeda, I., A comparison of hypocholesterolemic activity of beta-sitosterol and beta-sitostanol in rats. The Journal of Nutrition 107 (1977), 2011–2019.
51. Suomela, J.P., Ahotupa, M., Yang, B., Vasankari, T., Kallio, H., Absorption of flavonols derived from sea buckthorn (Hippophae rhamnoides L.) and their effect on emerging risk factors for cardiovascular disease in humans. Journal of Agricultural and Food Chemistry 54 (2006), 7364–7369.
52. Suryakumar, G., Gupta, A., Medicinal and therapeutic potential of Sea buckthorn (Hippophae rhamnoides L.). Journal of Ethnopharmacol 138 (2011), 268–278.
53. Upadhyay, N., Kumar, R., Mandotra, S., Meena, R., Siddiqui, M., Sawhney, R., et al. Safety and healing efficacy of Sea buckthorn (Hippophae rhamnoides L.) seed oil on burn wounds in rats. Food and Chemical Toxicology 47 (2009), 1146–1153.
54. Vijaimohan, K., Jainu, M., Sabitha, K., Subramaniyam, S., Anandhan, C., Devi, C.S., Beneficial effects of alpha linolenic acid rich flaxseed oil on growth performance and hepatic cholesterol metabolism in high fat diet fed rats. Life Sciences 79 (2006), 448–454.
55. Vita, J.A., Polyphenols and cardiovascular disease: Effects on endothelial and platelet function. The American Journal of Clinical Nutrition 81 (2005), 292S–297S.
56. Wang, J., Zhang, W., Zhu, D., Zhu, X., Pang, X., Qu, W., Hypolipidaemic and hypoglycaemic effects of total flavonoids from seed residues of Hippophae rhamnoides L. in mice fed a high-fat diet. Journal of the Science of Food and Agriculture 91 (2011), 1446–1451.
57. Wu, Y., Zhang, D., Jiang, X., Jiang, W., Fruit and vegetable consumption and risk of type 2 diabetes mellitus: A dose-response meta-analysis of prospective cohort studies. Nutrition, Metabolism and Cardiovascular Diseases 25 (2015), 140–147.
58. Xue, Y., Miao, Q., Zhao, A., Zheng, Y., Zhang, Y., Wang, P., et al. Effects of sea buckthorn (Hippophaë rhamnoides) juice and L-quebrachitol on type 2 diabetes mellitus in db/db mice. Journal of Functional Foods 16 (2015), 223–233.
59. Xu, Y.-J., Kaur, M., Dhillon, R.S., Tappia, P.S., Dhalla, N.S., Health benefits of sea buckthorn for the prevention of cardiovascular diseases. Journal of Functional Foods 3 (2011), 2–12.
60. Yang, C., Clinical research of hippophae dried emulsion on blood lipids and antioxidation. Hippophae 8 (1995), 80–83 (Chinese).
61. Yang, B., Kalimo, K.O., Mattila, L.M., Kallio, S.E., Katajisto, J.K., Peltola, O.J., et al. Effects of dietary supplementation with sea buckthorn (Hippophae rhamnoides) seed and pulp oils on atopic dermatitis. Journal of Nutritional Biochemistry 10 (1999), 622–630.
62. Yang, X., Qu, W., Xu, Z., Miu, Q., Zhu, L., Xu, Z., Effect of flavonoids from Hippophae rhamniodes residues on blood lipoid metabolism and ntioxidative activity in climacteric rats. China Journal of Chinese Materia Medica 31 (2006), 1109–1112 (Chinese).
63. Yang, X., Qu, W., Xu, Z., Shao, G., Zhang, W., Yang, Y., Effect of flavonoids from seed residues and oil of Hippophae Rhamnoides L. on serum lipid of femal aged rats with obesity. Acta Nutrimenta Sinica 29 (2007), 284–287 (Chinese).
64. Zak, A., Zeman, M., Vitkova, D., Hrabak, P., Tvrzicka, E., Beta-sitosterol in the treatment of hypercholesterolemia. Casopis lekaru ceskych 129 (1990), 1320–1323.
65. Zhan, S., Ho, S.C., Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. The American Journal of Clinical Nutrition 81 (2005), 397–408.
66. Zhang, W., Zhao, J., Wang, J., Pang, X., Zhuang, X., Zhu, X., Qu, W., Hypoglycemic effect of aqueous extract of seabuckthorn (Hippophae rhamnoides L.) seed residues in streptozotocin-induced diabetic rats. Phytotherapy Research 24 (2010), 228–232.
67. Zhao, Y., Asimi, S., Wu, K., Zheng, J., Li, D., Black tea consumption and serum cholesterol concentration: Systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition 34 (2014), 612–619.
68. Zheng, J.-S., Xu, A., Huang, T., Yu, X., Li, D., Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China. Lipids 47 (2012), 549–556.
69. Zheng, X.-X., Xu, Y.-L., Li, S.-H., Liu, X.-X., Hui, R., Huang, X.-H., Green tea intake lowers fasting serum total and LDL cholesterol in adults: A meta-analysis of 14 randomized controlled trials. The American Journal of Clinical Nutrition 94 (2011), 601–610.
70. Zou, Y., Xu, R., Liu, L., Yang, X., Seabuckthorn anthocyanin soft capsule” antioxidant testing for human. The Global Seabuckthorn Research and Development 8 (2010), 7–10 (Chinese).